The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

NCT04659239 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

34020

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell)
BIOLOGICAL: Placebo

Sponsor

Chinese Academy of Medical Sciences